PolarityTE(TM) Appoints Clinical Expert and Industry Insider Dr. Wayne Saunders to the Clinical Board of Advisors

PolarityTE(TM) Appoints Clinical Expert and Industry Insider Dr. Wayne Saunders to the Clinical Board of Advisors

SALT LAKE CITY, UT — (Marketwired) — 06/21/17 — PolarityTE, Inc. (NASDAQ: COOL) today announced the appointment of Wayne J. Saunders, DMD to the Company–s Clinical Board of Advisors. Dr. Saunders is Chief of Oral and Maxillofacial Surgery and Dentistry at St. Luke–s University Hospital in Bethlehem, PA, and is widely-regarded as an expert in dental implants and maxillofacial trauma."As we develop the PolarityTE technology platform, we continue to leverage the experience and knowledge

PolarityTE(TM), Inc. Enters Formal Agreement with Cell Therapy and Regenerative Medicine, A Leading Cell Therapy Manufacturer in the Intermountain West

PolarityTE(TM), Inc. Enters Formal Agreement with Cell Therapy and Regenerative Medicine, A Leading Cell Therapy Manufacturer in the Intermountain West

SALT LAKE CITY, UT — (Marketwired) — 04/20/17 — PolarityTE, Inc. ("Polarity") (NASDAQ: COOL) announces the signing of a manufacturing agreement with Cell Therapy and Regenerative Medicine ("CTRM") at the University of Utah School of Medicine. CTRM is the established manufacturer of hematopoietic stem cell transplants for renowned institutions of the Salt Lake region such as the Huntsman Cancer Institute and Primary Children–s Hospital. In addition, CTRM manufactures a va

PolarityTE(TM) Inc. Announces Completion of Merger and Acquires Important Intellectual Property for Regenerative Medicine Programs

PolarityTE(TM) Inc. Announces Completion of Merger and Acquires Important Intellectual Property for Regenerative Medicine Programs

SALT LAKE CITY, UT — (Marketwired) — 04/07/17 — PolarityTE, Inc., (NASDAQ: COOL) today announced the completion of a previously announced merger. The Company will continue to trade under the NASDAQ symbol COOL.Denver Lough, Chairman and Chief Executive Officer of Polarity, stated, "We are thrilled and excited to announce the completion of this merger, which we believe dramatically propels the future development of PolarityTE. Numerous parties have dedicated tremendous amounts of work br

Global Burn Surgery Expert Dr. Stephen Milner is Recruited from Role as Director of The Johns Hopkins Burn Center and is Appointed as Chief Clinical Officer of PolarityTE(TM), Inc.

SOUTH PLAINFIELD, NJ — (Marketwired) — 03/27/17 — PolarityTE, Inc. ("Polarity") (NASDAQ: COOL) announces that Dr. Stephen Milner (drstephenmilner.org) will join the company in a full-time capacity as Chief Clinical Officer following his resignation from Johns Hopkins as Professor of Plastic and Reconstructive Surgery and Pediatrics and Director of the Burn Center on March 30, 2017.As Chief Clinical Officer, Dr. Milner will utilize his extensive network of burn and wound care surgeo

PolarityTE(TM) Inc. Appoints Business Strategy and Innovation Expert Jeff Dyer, MBA, PhD to Board of Directors

SOUTH PLAINFIELD, NJ — (Marketwired) — 03/08/17 — , (NASDAQ: COOL) today announced it has appointed Jeff Dyer, MBA, PhD, expert in business strategy and innovation to its Board of Directors."As we bring the vision of PolarityTE to fruition, we are excited to announce the appointment of a world class business strategist and scholar in innovation like Jeff Dyer to our Board of Directors. His career both working in the formative years of Bain & Company and studying the most innovative

PolarityTE(TM) Inc. Appoints Artificial Intelligence and Cognitive Computing Leader Burke Powers as VP of Product Development

PolarityTE(TM) Inc. Appoints Artificial Intelligence and Cognitive Computing Leader Burke Powers as VP of Product Development

SOUTH PLAINFIELD, NJ — (Marketwired) — 02/28/17 — , (NASDAQ: COOL) today announced it has appointed Burke Powers as Vice President of Product Development. Mr. Powers has extensive experience building and commercializing products both in healthcare and other sectors utilizing artificial intelligence and big data anlytics."The addition of Burke Powers to PolarityTE marks yet another major milestone as we assemble the pieces to fulfill our vision to approach tissue engineering from a new p

PolarityTE(TM) Inc. Regains Compliance With NASDAQ Independent Director Requirement

PolarityTE(TM) Inc. Regains Compliance With NASDAQ Independent Director Requirement

SOUTH PLAINFIELD, NJ — (Marketwired) — 02/22/17 — , (NASDAQ: COOL) today announced it has received formal notification from the Listing Qualifications Department of The NASDAQ Stock Market ("NASDAQ") notifying PolarityTE that it has regained compliance with Listing Rule 5605(b)(1), the independent director requirement for continued listing on The NASDAQ Stock Market, with the appointment of Mr. Steve Gorlin and Dr. Jon Mogford, and that the matter is now closed. PolarityTE–s commo

PolarityTE(TM) Inc. Appoints Jon Mogford, PhD to the Board of Directors

PolarityTE(TM) Inc. Appoints Jon Mogford, PhD to the Board of Directors

SOUTH PLAINFIELD, NJ — (Marketwired) — 02/16/17 — , (NASDAQ: COOL) today announced it has appointed Jon Mogford, PhD to the Board of Directors. Dr. Mogford has extensive experience in regenerative medicine and wound healing, with a long track record of leading large research institutions. He currently oversees research strategy as Vice Chancellor for Research across the entire Texas A&M University System, and led significant expansion and collaborations while serving as Deputy Director o